Trial Profile
Efficacy of sitafloxacin as third-line eradication treatment of Helicobacter pylori
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 22 Jul 2015
Price :
$35
*
At a glance
- Drugs Sitafloxacin (Primary) ; Amoxicillin; Rabeprazole
- Indications Helicobacter pylori infections
- Focus Therapeutic Use
- 04 Apr 2011 New trial record